CTI Clinical Research Center
CTI is a global contract research organization (CRO) with experience in clinical trials across six continents. CTI works with sponsors, research sites, and patients to develop treatments that improve health and the lives of people around the world. Its headquarters are in Greater Cincinnati, OH, and it has operations in North America, Europe, Latin America, and MEA. CTI also has a presence in Asia-Pacific.
CTI Clinical Trial and Consulting Services is a full-service contract research organization that conducts clinical trials and consulting services for pharmaceutical companies worldwide. The company’s specialty areas include transplantation, immunology, and rare disease research. The company’s clinical research centers are located in Cincinnati, Ohio, and provide a multidisciplinary approach to drug development.
CTI has an extensive track record in clinical research across 6 continents and works with sponsors, research sites, and patients in order to conduct trials that lead to new drugs and medical innovations. With offices across North America, Europe, Latin America, MEA, and Asia-Pacific, CTI is one of the largest clinical research organizations in the world.
global contract research organization
The global contract research organization market is segmented by services and application, such as oncology, infectious diseases, immunological disorders, metabolic disorders, respiratory diseases, neurological disorders, and others. The global contract research organization market is expected to witness significant growth over the next five years, driven by a plethora of new medicines and increasing investments in research and development. In addition, tighter regulatory requirements have increased the complexity of clinical trials, which further drives the growth of the contract research organization market.
The global contract research organization market is composed of services and related goods, and services are offered by domestic and foreign-based companies. These companies provide services ranging from data entry and quality and metric reporting to clinical trial management and coordination.
Phase I unit
CTI Clinical Research Center’s Phase I unit is an industry-leading facility for early-phase clinical pharmacology trials. The CRC has completed more than 200 sleep studies, and contributed to the development of 17 approved sleep medications in the last two decades. The team also has extensive experience in clinical trials spanning a range of specialties and indications.
CTI CRC is part of a larger global clinical research organization, CTI CRO, that specializes in complex programs in critical-ill patient populations. With offices in North America, Europe, and South America, CTI CRC is able to provide full-service support solutions to companies seeking to conduct clinical trials. Its multi-specialty research staff consists of expert clinical pharmacology, pharmacokinetics, and drug metabolism experts.
Phase II-IV experience
The CTI Clinical Research Center (CRC) is a fully equipped, state-of-the-art facility designed to conduct early phase clinical pharmacology trials. As an industry leader in sleep research, the CRC has conducted over 200 sleep studies and contributed to the approval of 17 sleep drugs in the last two decades. CTI’s extensive Phase II-IV experience includes comprehensive human clinical trials across a wide range of indications and specialties.
CTI’s clinical research team has years of experience delivering successful clinical trials for the biotechnology, pharmaceutical, and medical device industry. Its team of experienced professionals is committed to providing high-quality clinical trials while ensuring confidentiality and teamwork. The company’s management team also carefully monitors project costs and performance against contractual deadlines.